Published in Women's Health Weekly, September 21st, 1998
MedImmune's parvovirus B 19 vaccine candidate, which has potential use for women of childbearing age, has completed a Phase I clinical trial, and its E. coli vaccine candidate for urinary tract infections is expected to enter the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly